Sapna Srivastava's most recent trade in Nuvalent Inc - Ordinary Shares - Class A was a trade of 4,147 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvalent Inc - Ordinary Sh... | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 4,147 | 4,147 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 2,647 | 5,146 | - | 0 | Class A Common Stock | |
| Aura Biosciences Inc | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 13,000 | 23,500 | - | 0 | Common Stock | |
| Tourmaline Bio Inc | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 16,800 | 16,800 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 29,946 | 29,946 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Sapna Srivastava | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 29,946 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 28,877 | 28,877 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Sapna Srivastava | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 28,877 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 28,877 | 28,877 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 14,500 | 14,500 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 10,500 | 10,500 | - | 0 | Common Stock | |
| Innoviva Inc | Sapna Srivastava | Director | 17 Jun 2024 | 13,923 | 44,096 (0%) | 0% | 0 | Common Stock | ||
| Innoviva Inc | Sapna Srivastava | Director | 17 Jun 2024 | 10,000 | 22,500 | - | - | Non-statutory Stock Option | ||
| Nuvalent Inc - Ordinary Sh... | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 3,789 | 3,789 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,499 | 2,499 | - | 0 | Class A Common Stock | |
| Tourmaline Bio Inc | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Innoviva Inc | Sapna Srivastava | Director | 22 May 2023 | 16,495 | 30,173 (0%) | 0% | 0 | Common Stock | ||
| Innoviva Inc | Sapna Srivastava | Director | 22 May 2023 | 10,000 | 12,500 | - | - | Non-statutory Stock Option | ||
| Nuvalent Inc - Ordinary Sh... | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Talaris Therapeutics Inc | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 14,501 | 14,501 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2021 | 68,500 | 68,500 | - | - | Stock Option (Right to Buy) |